Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: Quantification of CD34+ cells by polymerase chain reaction

Haematologica

Volumn 90, Issue 7, 2005, Pages 875-880

  Leibundgut, Elisabeth Oppliger ^a   Brunold, Claudio ^a   Marti, Dorothee ^a   Horn, Michael Peter ^a   Seiler, Christian ^a,b   Schroeder, Verena ^b   Schmid, Jean Paul ^b   Tobler, Andreas ^a   Zwicky, Caroline ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

CD34; Ischemic cardiopathy; Myeloproliferative diseases; PCR; Trafficking

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL MOTION; CONTROLLED STUDY; ERYTHROCYTOSIS; FEMALE; GENE EXPRESSION; HUMAN; ISCHEMIC HEART DISEASE; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; STEM CELL; THROMBOCYTHEMIA; THROMBOCYTOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION;

EID: 22544487239     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science 2001;294:1933-6.
2. Vasa M, Fichtischerer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number of migratory activity of circulating endothelial progenitor cells inversely correlate with the risk factors for coronary artery disease. Circulation Res 2001;89:E1-7.
3. Eizawa T, Ikeda U, Murakami Y, Matsui K, Yoshioka T, Suzuki C, et al. Increase in circulating endothelial progenitor cells after aortic aneurysm repair. Hearth Vessels 2004;19:107-10.
4. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004;109:2986-92.
5. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2004;1831:1-38.
6. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004;109:2972-5.
7. Andreasson B, Swolin B, Kutti, J. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia. Eur J Haematol 2000;64:188-93.
8. Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M, et al. Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia. Blood 2001;98:3249-55.
9. Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, et al. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. Haematologica 2003;88:1123-9.
10. Gratama JW, Orfao A, Barnett D, Brando B, Huber A, Janossy C, et al. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. Cytometry 1998;34:128-42.
11. Zwicky C, Theiler L, Zbaeren K, Ischi E, Tobler A. The predictive value of clonogenic stem cell assays for the diagnosis of polycythaemia vera. Br J Haematol 2002;117:598-604.
12. Sagaster V, Jaeger E, Weltermann A, Schwarzinger I, Gisslinger H, Lechner K, et al. Circulating haematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia. Haematologica 2003;88:1204-12.